Brief: Theravance Biopharma Expects To Complete Pifr-2 Study And Provide Top-Line Results In 2H 2023
09/01/2023 11:52
Jan 9 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA INC - EXPECTS TO COMPLETE PIFR-2
STUDY AND
PROVIDE TOP-LINE RESULTS IN 2H 2023
* THERAVANCE BIOPHARMA INC - EXPECTS TO GENERATE NON-GAAP
PROFIT
IN 2H 2023
Source text for Eikon: ID:nPn23pvtJa
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions